The treatment for cancer vs shorters (IBRX) BUY BUY BUY

u/Massive-Sale4530 · Reddit — r/wallstreetbets · January 23, 2026 at 14:52 · ⬆ 3 pts · 💬 2 comments  | View on Reddit ↗
AI Summary

Original Reddit post

Bullish post on ImmunityBio (IBRX) citing successful early trials in lung and bladder cancer and a 105% short reserve rate.

IBRX — LONG The author argues ImmunityBio developed a medicine that succeeded in early trials for lung and bladder cancer, providing a clinical catalyst for the stock. The mechanism cited is a massively improving financial position combined with shorters facing a 105% reserve rate, which the author expects to force covering and drive the price higher. No specific risk is stated.

Immunity bio developed and succeeded in its early trials of its medicine for lung and bladder cancer. Along with that is a massively improving financial position with shorters having to deal with a 105% reserve rate at the time of writing this.

Score 3
Comments 2
▶ Full Post Text
Ideas
u/Massive-Sale4530 Reddit r/wallstreetbets
IBRX long on trial success and short squeeze
The author argues ImmunityBio developed a medicine that succeeded in early trials for lung and bladder cancer, providing a clinical catalyst for the stock. The mechanism cited is a massively improving financial position combined with shorters facing a 105% reserve rate, which the author expects to force covering and drive the price higher. No specific risk is stated.
IBRX MED
More from Reddit — r/wallstreetbets
Not a huge amount of money, but it doesn’t get much worse than this percentage
Jan 23, 14:48
The only 3 tickers you need
Jan 23, 14:43
$54000 profit from $39000 intel short position
Jan 23, 14:36
And we’re back 😏
Jan 23, 14:35
So much upside for Tesla over the next year if they execute properly
Jan 23, 14:30

This Reddit post, published January 23, 2026, features u/Massive-Sale4530 discussing IBRX. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: u/Massive-Sale4530  · Tickers: IBRX